The NextGen Precision Health Discovery Series provides learning opportunities for UM System faculty and staff across disciplines, the statewide community and our other partners to learn about the scope of precision health research and identify potential collaborative opportunities. The series consists of monthly lectures geared toward a broad multidisciplinary audience so all can participate and appreciate the spectrum of precision health efforts.
Information about this upcoming talk, including continuing education, is available below.
For questions about this event or any others in the Discovery Series, please reach out to Veronica Lemme at lemmev@health.missouri.edu.
“Translational Research in the Era of Precision Medicine: Enhancing Care if Cure Is Not Possible”
Speaker: David Fleming, M.D., M.A., Professor Emeritus of Medicine and Emeritus Chair of the Department of Medicine at the University of Missouri School of Medicine, Fellow of the Royal College of Physicians
Date: May 14, 2024, noon-1 p.m.
Location: Patient-Centered Care Learning Center, Room LC230, University of Missouri School of Medicine
Description
Dr. Fleming will be talking about the intersection of clinical medicine with translational research in the era of precision medicine and the potential impact scientific discovery can have on enhancing trust in the healing relationship and improving communication in complex decision-making at the bedside, particularly at the end of life.
Ƶ the Speaker
Dr. Fleming is Professor Emeritus of Medicine and Emeritus Chair of the Department of Medicine at the University of Missouri School of Medicine (2009-2016); he also is the founding director of the Center for Health Ethics at that institution (2001), where he continues to serve as senior scholar. From 1999-2001, he was a U.S. Department of Health and Human Services primary care research fellow at the Center for Clinical Bioethics at Georgetown University, where he also received a master of arts in ethics and the professions. In addition to many scholarly works, he is lead editor and author of the book “Care of the Dying Patient.” Dr. Fleming was president of the American College of Physicians from 2014-2015 and served as a member of the Board of Regents for the National Institutes of Health — National Library of Medicine from 2011-2015. He has been a member of the Council on Ethics and Judicial Affairs of the American Medical Association for over six years and presently serves as chair.
Continuing Professional Education Credit
Successful Completion of this activity, which includes participating in the educational offering, participating in the evaluation process and completing the verification of attendance, enables the learner to satisfy the requirements for continuing education.
Nursing Contact Hours
University of Missouri Sinclair School of Nursing is approved as a provider of nursing continuing professional development by the Midwest Multistate Division, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation (ANCC).
1.0 contact hour may be awarded.
Physicians
The University of Missouri-Columbia School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University of Missouri-Columbia School of Medicine designates this live educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
Financial Relationships
Current ACCME and Midwest Multistate Division, ANCC rules state that participants in continuing education activities should be made aware of any relevant affiliation or financial interest in the previous 24 months that may affect the planning of an educational activity or a speaker’s presentation(s). Each planning committee member and speaker has been requested to complete a financial relationship reporting form for the NextGen Precision Health Discovery Series. No planning committee member or speaker has a relevant financial interest.
Reviewed 2024-06-06